Last reviewed · How we verify

Omnitrope — Competitive Intelligence Brief

Omnitrope (Omnitrope) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Other.

marketed Growth hormone receptor Other Small molecule Live · refreshed every 30 min

Target snapshot

Omnitrope (Omnitrope) — Sandoz.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Omnitrope TARGET Omnitrope Sandoz marketed Growth hormone receptor
Ngenla Somatrogon-Ghla Pfizer Ireland Pharmaceuticals marketed Growth hormone receptor 2023-01-01
Ngenla somatrogon Pfizer Ireland Pharmaceuticals marketed Growth hormone receptor 2023-01-01
Skytrofa LONAPEGSOMATROPIN Ascendis Pharma Encocrinology Div A/S marketed Recombinant Human Growth Hormone [EPC] Growth hormone receptor 2021-01-01
Sogroya SOMAPACITAN Novo Nordisk marketed Growth hormone receptor 2020-01-01
Trovert somavert Pfizer marketed Growth Hormone Receptor Antagonist Growth hormone receptor 2003-01-01
Trovert PEGVISOMANT Pfizer marketed Growth Hormone Receptor Antagonist Growth hormone receptor 2003-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Omnitrope — Competitive Intelligence Brief. https://druglandscape.com/ci/omnitrope. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: